NASDAQ:IVVD - Nasdaq - US00534A1025 - Common Stock - Currency: USD
Taking everything into account, IVVD scores 3 out of 10 in our fundamental rating. IVVD was compared to 562 industry peers in the Biotechnology industry. The financial health of IVVD is average, but there are quite some concerns on its profitability. IVVD has a correct valuation and a medium growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -131.2% | ||
ROE | -251.59% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 93.63% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | -12.73 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.62 | ||
Quick Ratio | 1.62 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 8.47 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:IVVD (5/13/2025, 9:57:04 AM)
0.9791
+0.14 (+16.87%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 8.47 | ||
P/S | 4.63 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 1.74 | ||
P/tB | 1.74 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -131.2% | ||
ROE | -251.59% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 93.63% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 4.5% | ||
Cap/Sales | 0.55% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 1.62 | ||
Quick Ratio | 1.62 | ||
Altman-Z | -12.73 |